Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.3.1 (
citrate synthase
)
4,488
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The main aim of this study was to investigate whether enzyme levels of the malate-aspartate and alpha-glycerophosphate shuttles and of
cytochrome b5 reductase
in human skeletal muscle are affected by strength training. Muscle biopsy samples from the deltoid muscle of the nondominant arm in untrained (n = 12) and strength-trained (n = 12) subjects were compared. The strength-trained muscles were characterized by a tendency to a higher percentage of type I fibers (67 vs. 59%), a lower percentage of type IIb fibers (12 vs. 18%), 34% larger mean fiber areas, and 19% more capillaries per fiber (P less than 0.1). No difference was noted in levels of enzymes representing the citric acid cycle, fatty acid oxidation, and glycolysis, nor in the number of capillaries per square millimeter. Neither did the levels of malate-aspartate and alpha-glycerophosphate shuttle enzymes nor
cytochrome b5 reductase
differ. Levels of
cytochrome b5 reductase
correlated (r = 0.59, P less than 0.01) with levels of the mitochondrial marker enzyme
citrate synthase
. It is concluded that strength training does not appear to result in increased levels of NADH shuttle enzymes and
cytochrome b5 reductase
.
...
PMID:NADH shuttle enzymes and cytochrome b5 reductase in human skeletal muscle: effect of strength training. 252 25